HUP0003164A3 - Vaccine compositions comprising the helicobacter pylori flge polypeptide - Google Patents
Vaccine compositions comprising the helicobacter pylori flge polypeptideInfo
- Publication number
- HUP0003164A3 HUP0003164A3 HU0003164A HUP0003164A HUP0003164A3 HU P0003164 A3 HUP0003164 A3 HU P0003164A3 HU 0003164 A HU0003164 A HU 0003164A HU P0003164 A HUP0003164 A HU P0003164A HU P0003164 A3 HUP0003164 A3 HU P0003164A3
- Authority
- HU
- Hungary
- Prior art keywords
- helicobacter pylori
- vaccine compositions
- flge polypeptide
- pylori flge
- polypeptide
- Prior art date
Links
- 241000590002 Helicobacter pylori Species 0.000 title 1
- 229940037467 helicobacter pylori Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702242A SE9702242D0 (sv) | 1997-06-12 | 1997-06-12 | Vaccine compositions V |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0003164A2 HUP0003164A2 (hu) | 2000-12-28 |
HUP0003164A3 true HUP0003164A3 (en) | 2001-10-29 |
Family
ID=20407351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0003164A HUP0003164A3 (en) | 1997-06-12 | 1998-06-08 | Vaccine compositions comprising the helicobacter pylori flge polypeptide |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1009764A1 (hu) |
JP (1) | JP2002507118A (hu) |
KR (1) | KR20010013699A (hu) |
CN (1) | CN1259960A (hu) |
AR (1) | AR012896A1 (hu) |
AU (1) | AU8048798A (hu) |
BR (1) | BR9810026A (hu) |
CA (1) | CA2293293A1 (hu) |
EE (1) | EE9900566A (hu) |
HU (1) | HUP0003164A3 (hu) |
ID (1) | ID23052A (hu) |
IL (1) | IL133144A0 (hu) |
IS (1) | IS5288A (hu) |
NO (1) | NO996132L (hu) |
NZ (1) | NZ501427A (hu) |
PL (1) | PL337503A1 (hu) |
SE (1) | SE9702242D0 (hu) |
SK (1) | SK173099A3 (hu) |
TR (1) | TR199903060T2 (hu) |
WO (1) | WO1998056816A1 (hu) |
ZA (1) | ZA984696B (hu) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104784687A (zh) * | 2015-04-27 | 2015-07-22 | 苏州大学附属第一医院 | 重组绿脓杆菌鞭毛钩蛋白FlgE的用途 |
CN113425717B (zh) * | 2021-04-22 | 2023-06-16 | 成都欧林生物科技股份有限公司 | 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用 |
CN116535472B (zh) * | 2023-05-31 | 2024-04-30 | 四川大学华西医院 | 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用 |
CN118105473B (zh) * | 2024-04-30 | 2024-08-16 | 成都欧林生物科技股份有限公司 | 一种预防或治疗Hp感染口服免疫原性组合物及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
AR003125A1 (es) * | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
-
1997
- 1997-06-12 SE SE9702242A patent/SE9702242D0/xx unknown
-
1998
- 1998-06-01 ZA ZA984696A patent/ZA984696B/xx unknown
- 1998-06-01 AR ARP980102558A patent/AR012896A1/es unknown
- 1998-06-08 HU HU0003164A patent/HUP0003164A3/hu unknown
- 1998-06-08 AU AU80487/98A patent/AU8048798A/en not_active Abandoned
- 1998-06-08 IL IL13314498A patent/IL133144A0/xx unknown
- 1998-06-08 PL PL98337503A patent/PL337503A1/xx unknown
- 1998-06-08 JP JP50228399A patent/JP2002507118A/ja active Pending
- 1998-06-08 EE EEP199900566A patent/EE9900566A/xx unknown
- 1998-06-08 WO PCT/SE1998/001093 patent/WO1998056816A1/en not_active Application Discontinuation
- 1998-06-08 ID IDW991542A patent/ID23052A/id unknown
- 1998-06-08 BR BR9810026-2A patent/BR9810026A/pt not_active IP Right Cessation
- 1998-06-08 CN CN98806101A patent/CN1259960A/zh active Pending
- 1998-06-08 EP EP98928772A patent/EP1009764A1/en not_active Withdrawn
- 1998-06-08 SK SK1730-99A patent/SK173099A3/sk unknown
- 1998-06-08 CA CA002293293A patent/CA2293293A1/en not_active Abandoned
- 1998-06-08 TR TR1999/03060T patent/TR199903060T2/xx unknown
- 1998-06-08 NZ NZ501427A patent/NZ501427A/xx unknown
- 1998-06-08 KR KR1019997011714A patent/KR20010013699A/ko not_active Application Discontinuation
-
1999
- 1999-12-08 IS IS5288A patent/IS5288A/is unknown
- 1999-12-10 NO NO996132A patent/NO996132L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1259960A (zh) | 2000-07-12 |
JP2002507118A (ja) | 2002-03-05 |
SE9702242D0 (sv) | 1997-06-12 |
AU8048798A (en) | 1998-12-30 |
IL133144A0 (en) | 2001-03-19 |
ID23052A (id) | 2000-01-20 |
SK173099A3 (en) | 2000-06-12 |
WO1998056816A1 (en) | 1998-12-17 |
IS5288A (is) | 1999-12-08 |
HUP0003164A2 (hu) | 2000-12-28 |
TR199903060T2 (xx) | 2000-09-21 |
NZ501427A (en) | 2000-09-29 |
NO996132L (no) | 2000-01-28 |
EE9900566A (xx) | 2000-06-15 |
EP1009764A1 (en) | 2000-06-21 |
BR9810026A (pt) | 2000-09-19 |
AR012896A1 (es) | 2000-11-22 |
KR20010013699A (ko) | 2001-02-26 |
ZA984696B (en) | 1999-01-04 |
CA2293293A1 (en) | 1998-12-17 |
PL337503A1 (en) | 2000-08-28 |
NO996132D0 (no) | 1999-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL337488A1 (en) | Oil-in-water type compositions for vaccines | |
IL122340A0 (en) | Helicobacter pylori antigens and vaccine compositions | |
ZA978868B (en) | Vaccine composition | |
AU8005098A (en) | Alpha1,3-fucosyltransferase of helicobacter pylori | |
HK1039068A1 (en) | Antigenic peptides derived from telomerase | |
ZA9610945B (en) | Novel compositions with activity against helicobacter | |
ZA976815B (en) | Vaccine composition. | |
GB9623233D0 (en) | Vaccine composition | |
EP0998942A4 (en) | METHOD FOR STABILIZING PEPTIDES AND FREEZERED MEDICINAL COMPOSITIONS THEREOF | |
HU9600207D0 (en) | Vaccine compositions | |
AU1698699A (en) | (helicobacter pylori) vaccine formulations | |
HUP0003164A3 (en) | Vaccine compositions comprising the helicobacter pylori flge polypeptide | |
HK1026626A1 (en) | Immunopotentiating formulations for vaccinal use. | |
AU8048698A (en) | Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide | |
AU7945798A (en) | Vaccine compositions comprising the (helicobacter pylori) 26kda polypeptide | |
GB9413073D0 (en) | Helicobacter pylori vaccines/therapeutic compositions | |
GB9614618D0 (en) | Vaccine compositions | |
ZA98588B (en) | H. Pylori antigens. | |
ZA972566B (en) | Polysorbate-containing compositions and their use against Helicobacter. | |
AU4789400A (en) | (helicobacter pylori) antigens | |
GB9705460D0 (en) | Polynucleotide vaccine formulations | |
GB9714333D0 (en) | Rotavirus vaccine formulations | |
GB9622439D0 (en) | Vaccine composition | |
GB9622437D0 (en) | Vaccine composition | |
ZA978586B (en) | Rotavirus vaccine formulations. |